Purchase Order 75N94022P00404
Award Date
5/31/22
Potential Completion Date
1/15/23
Potential Value
$12K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Gempharmatech LLC
Ultimate Awardee
Not listed
NAICS Category
112990 - All Other Animal Production
PSC Category
8820 - Live Animals, Not Raised For Food
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Talleyville, DE 19803, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...
This is a firm fixed-price federal contract award from the Veterans Integrated Service Network 12, a civilian agency, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the generation of PGP/MDR1A floxed live mice, a specialized mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of March 14, 2025. Gempharmatech has previously received similar contract awards...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, with a ceiling value of $67,700.00, is for the provision of genetically modified (GM) mice and rats to support...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Cyagen US Inc., a biotechnology company specializing in knockout and transgenic mouse models. The $97,577 contract is for Cyagen to provide "TurboKnockout" mouse gene targeting services to support biomedical research projects funded by NICHD. The contract has a completion date of June 22, 2021 and was awarded on a sole-source basis, as Cyagen's proprietary...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $13,953 purchase order to Genoway of France. The contract calls for Genoway to develop a H3.3B conditional knockout mouse embryonic stem cell line to support NICHD's research efforts. Performance will take place in France over a six-week period concluding in mid-October 2014. The contract utilizes a firm fixed price structure. No additional details...
This federal contract award is for HHSN272200900005I|HHSN27200027, a Delivery Order issued to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' (HHS) National Institutes of Health (NIH), and has a ceiling value of $70,800.00. The contract scope includes the...